NEA Management Company, LLC - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, NEA Management Company, LLC held in its portfolio 27 assets valued at $1,961,136,508 (i.e. $1.96B).
The most valuable assets in the portfolio included: Celcuity Inc. ($352.64M), Rhythm Pharmaceuticals, Inc. ($311.48M), and Arcellx, Inc. ($198.55M).
The chart below shows the top 10 valuable assets, and the table below shows the top 27 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
NEA Management Company, LLC - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| Celcuity Inc. | 3535561 | 352636854 | COM |
| Rhythm Pharmaceuticals, Inc. | 2909956 | 311481690 | COM |
| Arcellx, Inc. | 3045262 | 198551082 | COMMON STOCK |
| Trevi Therapeutics, Inc. | 13222228 | 165542295 | COM |
| Savara, Inc. | 24471264 | 147561722 | COM |
| Zenas BioPharma, Inc. | 3523219 | 127928082 | COM |
| Monte Rosa Therapeutics, Inc. | 7692298 | 120615233 | COM |
| MBX Biosciences, Inc. | 3614486 | 114000888 | COM |
| Coursera, Inc. | 12867769 | 94706780 | COM |
| Aurinia Pharmaceuticals, Inc. | 3969834 | 63318852 | COM |
| Gossamer Bio, Inc. | 18093034 | 56088405 | COM |
| CRISPR Therapeutics AG | 1058570 | 55511411 | NAMEN AKT |
| ORIC Pharmaceuticals, Inc. | 4118621 | 33690320 | COM |
| Phathom Pharmaceauticals, Inc. | 1960169 | 32519204 | COM |
| CVRx, Inc. | 2026083 | 14385189 | COM |
| X4 Pharmaceuticals, Inc. | 3233743 | 12934972 | COM |
| Champions Oncology, Inc. | 1713720 | 11841805 | COM NEW |
| Black Diamond Therapeutics, Inc. | 4448757 | 10810480 | COM |
| Korro Bio, Inc. | 1090793 | 8737252 | COM |
| Inventiva SA | 1462586 | 6801025 | ADS |
| Nkarta, Inc. | 3568781 | 6602245 | COM |
| Senti Biosciences, Inc. | 3775615 | 3926640 | COM NEW |
| LeonaBio, Inc. | 464398 | 3515493 | COM |
| Synlogic, Inc. | 2922772 | 3273505 | COM NEW |
| Marker Therapeutics, Inc. | 1625678 | 2422260 | COM NEW |
| OnKure Therapeutics, Inc. | 478548 | 1387789 | COM CL A |
| ImageneBio, Inc. | 50005 | 345035 | COM |